Elaine Gin

Elaine Gin serves as the Executive Director and Financial Evaluation & Analysis Lead at Organon since April 2021, following a tenure at Merck from April 2018 to April 2021 as the Director of Merck Research Labs Financial Services, where financial reporting and analysis focused on the research division's operating performance. Prior experience includes a six-month international assignment in Market Access & Pricing at MSD Australia in 2017-2018, and a role at Merck (2009-2017) as Director of Corporate Financial Evaluation & Analysis, overseeing financial analyses for corporate development activities. Earlier positions include managerial roles in financial evaluation and planning at Merck Manufacturing Division (2001-2008) and a directorial role in Capital Market Intelligence at Thomson Reuters (1996-2000). Elaine Gin holds a Bachelor's degree in Economics and Sociology, Magna Cum Laude, from Amherst College and an MBA in Finance from Columbia Business School.